指南与共识区域麻醉与超声术前评估与围术期医学

髋膝关节置换术麻醉管理:ICAROS国际共识推荐

Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis.
指南 / 共识 · Br J Anaesth · 2019-07-24

ICAROS组基于系统评价与荟萃分析(94项研究),比较髋/膝关节置换术中椎管内麻醉与全身麻醉的主要并发症。椎管内麻醉在几乎所有并发症上 odds 更低或无差异(尿潴留除外)。共识推荐髋关节置换术采用椎管内麻醉(证据中低,强推荐),膝关节置换术首选椎管内麻醉(证据低,弱推荐)。

要点

  • 髋关节置换术:推荐椎管内麻醉优于全身麻醉(证据中低,强推荐)。
  • 膝关节置换术:首选椎管内麻醉(证据低,弱推荐)。
  • 椎管内麻醉与多数并发症 odds 更低或无差异相关,尿潴留除外。

核心结论

  • 基于当前证据,共识组推荐髋/膝关节置换术采用椎管内麻醉而非全身麻醉。
  • 髋关节置换术:推荐椎管内麻醉(证据中低,强推荐)。
  • 膝关节置换术:首选椎管内麻醉(证据低,弱推荐)。

研究设计与样本

  • ICAROS组系统评价与荟萃分析,纳入比较椎管内与全身麻醉的随机对照和观察性研究。
  • 检索Medline、PubMed、Embase和Cochrane Library(1946年至2018年5月17日)。
  • 共分析94项研究,采用GRADE方法评估证据质量并形成推荐。

主要发现

  • 髋关节置换术椎管内 vs 全身麻醉:死亡率OR 0.67(95%CI 0.57-0.80);肺部并发症OR 0.65(95%CI 0.52-0.80);急性肾衰竭OR 0.69(95%CI 0.59-0.81);深静脉血栓OR 0.52(95%CI 0.42-0.65);感染OR 0.73(95%CI 0.67-0.79);输血OR 0.85(95%CI 0.82-0.89)。
  • 膝关节置换术椎管内 vs 全身麻醉:死亡率OR 0.83(95%CI 0.60-1.15);肺部并发症OR 0.69(95%CI 0.58-0.81);急性肾衰竭OR 0.73(95%CI 0.65-0.82);深静脉血栓OR 0.77(95%CI 0.64-0.93);感染OR 0.80(95%CI 0.76-0.85);输血OR 0.84(95%CI 0.82-0.87)。
  • 椎管内麻醉与几乎所有报告并发症的 odds 更低或无差异相关,尿潴留除外。

关键数值与推荐

  • 髋关节置换术:推荐椎管内麻醉(证据中低,强推荐)。
  • 膝关节置换术:首选椎管内麻醉(证据低,弱推荐)。

临床怎么用

  • 髋/膝关节置换术优先考虑椎管内麻醉而非全身麻醉,以改善术后结局。
  • 需权衡尿潴留风险,个体化选择麻醉方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence-based international expert consensus regarding anaesthetic practice in hip/knee arthroplasty surgery is needed for improved healthcare outcomes. METHODS: The International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) systematic review, including randomised controlled and observational studies comparing neuraxial to general anaesthesia regarding major complications, including mortality, cardiac, pulmonary, gastrointestinal, renal, genitourinary, thromboembolic, neurological, infectious, and bleeding complications. Medline, PubMed, Embase, and Cochrane Library including Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, NHS Economic Evaluation Database, from 1946 to May 17, 2018 were queried. Meta-analysis and Grading of Recommendations Assessment, Development and Evaluation approach was utilised to assess evidence quality and to develop recommendations. RESULTS: The analysis of 94 studies revealed that neuraxial anaesthesia was associated with lower odds or no difference in virtually all reported complications, except for urinary retention. Excerpt of complications for neuraxial vs general anaesthesia in hip/knee arthroplasty, respectively: mortality odds ratio (OR): 0.67, 95% confidence interval (CI): 0.57-0.80/OR: 0.83, 95% CI: 0.60-1.15; pulmonary OR: 0.65, 95% CI: 0.52-0.80/OR: 0.69, 95% CI: 0.58-0.81; acute renal failure OR: 0.69, 95% CI: 0.59-0.81/OR: 0.73, 95% CI: 0.65-0.82; deep venous thrombosis OR: 0.52, 95% CI: 0.42-0.65/OR: 0.77, 95% CI: 0.64-0.93; infections OR: 0.73, 95% CI: 0.67-0.79/OR: 0.80, 95% CI: 0.76-0.85; and blood transfusion OR: 0.85, 95% CI: 0.82-0.89/OR: 0.84, 95% CI: 0.82-0.87. CONCLUSIONS: Recommendation: primary neuraxial anaesthesia is preferred for knee arthroplasty, given several positive postoperative outcome benefits; evidence level: low, weak recommendation. RECOMMENDATION: neuraxial anaesthesia is recommended for hip arthroplasty given associated outcome benefits; evidence level: moderate-low, strong recommendation. Based on current evidence, the consensus group recommends neuraxial over general anaesthesia for hip/knee arthroplasty. TRIAL REGISTRY NUMBER: PROSPERO CRD42018099935.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Memtsoudis SG, Cozowicz C, Bekeris J, et al. Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis. Br J Anaesth. 2019. PMID: 31351590. doi:10.1016/j.bja.2019.05.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。